Literature DB >> 17294096

Possible mechanisms of the formation of chronic fatigue syndrome in the clinical picture of multiple sclerosis.

D S Kasatkin1, N N Spirin.   

Abstract

A frequent manifestation of multiple sclerosis (MS) is chronic fatigue syndrome, which can be defined as a subjective decrease in the level of physical and/or mental energy. Chronic fatigue syndrome can be divided into asthenia (fatigue at rest), pathological fatigability (fatigue on physical loading), and fatigue on the background of deterioration of other symptoms (exacerbation of MS). There are both central and peripheral mechanisms for the formation of fatigue. The combination of fatigue and affective disturbances, especially depression and sleep disorders (insomnia, restless legs syndrome) is common in MS and may provide evidence that they share common mechanisms--decreases in the activity of the serotoninergic and noradrenergic systems. An important component in the formation of chronic fatigue syndrome consists of endocrine and autoimmune factors, the latter having a greater effect on asthenia than on pathological fatigue. Further studies of the pathogenetic mechanisms of the formation of asthenia and pathological fatigue and clarification of their differential diagnostic signs should allow not only a better understanding of the nature of this syndrome, but also better selection of individual treatment.

Entities:  

Mesh:

Year:  2007        PMID: 17294096     DOI: 10.1007/s11055-007-0004-9

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  58 in total

1.  Serum carnitine and disabling fatigue in multiple sclerosis.

Authors:  T Fukazawa; H Sasaki; S Kikuchi; T Hamada; K Tashiro
Journal:  Psychiatry Clin Neurosci       Date:  1996-12       Impact factor: 5.188

2.  Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern.

Authors:  D C Kroencke; S G Lynch; D R Denney
Journal:  Mult Scler       Date:  2000-04       Impact factor: 6.312

3.  Correlation between symptom fatigue and muscular fatigue in multiple sclerosis.

Authors: 
Journal:  Eur J Neurol       Date:  1998-11       Impact factor: 6.089

4.  Adrenal cortical response to stress at Three Mile Island.

Authors:  M A Schaeffer; A Baum
Journal:  Psychosom Med       Date:  1984 May-Jun       Impact factor: 4.312

5.  Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera.

Authors:  S J Tzartos; D Sophianos; A Efthimiadis
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

6.  Symptomatic fatigue in multiple sclerosis.

Authors:  J E Freal; G H Kraft; J K Coryell
Journal:  Arch Phys Med Rehabil       Date:  1984-03       Impact factor: 3.966

7.  Amelioration of flulike symptoms at the onset of interferon beta-1b therapy in multiple sclerosis by low-dose oral steroids is related to a decrease in interleukin-6 induction.

Authors:  E M Martínez-Cáceres; J Río; M Barrau; I Durán; C Borrás; M Tintoré; X Montalban
Journal:  Ann Neurol       Date:  1998-10       Impact factor: 10.422

8.  The effect of immunomodulatory treatment on multiple sclerosis fatigue.

Authors:  L M Metz; S B Patten; C J Archibald; J I Bakker; C J Harris; D G Patry; R B Bell; M Yeung; W F Murphy; C A Stoian; K Billesberger; L Tillotson; S Peters; D McGowan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

9.  Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.

Authors:  Valentina Tomassini; Carlo Pozzilli; Emanuela Onesti; Patrizio Pasqualetti; Fabiana Marinelli; Angela Pisani; Cesare Fieschi
Journal:  J Neurol Sci       Date:  2004-03-15       Impact factor: 3.181

10.  Psychosocial correlates of fatigue in multiple sclerosis.

Authors:  C E Schwartz; L Coulthard-Morris; Q Zeng
Journal:  Arch Phys Med Rehabil       Date:  1996-02       Impact factor: 3.966

View more
  3 in total

1.  Early-life hygiene-related factors affect risk of central nervous system demyelination and asthma differentially.

Authors:  A-M Hughes; R M Lucas; A J McMichael; T Dwyer; M P Pender; I van der Mei; B V Taylor; P Valery; C Chapman; A Coulthard; K Dear; T J Kilpatrick; D Williams; A-L Ponsonby
Journal:  Clin Exp Immunol       Date:  2013-06       Impact factor: 4.330

2.  A brain MRI study of chronic fatigue syndrome: evidence of brainstem dysfunction and altered homeostasis.

Authors:  Leighton R Barnden; Benjamin Crouch; Richard Kwiatek; Richard Burnet; Anacleto Mernone; Steve Chryssidis; Garry Scroop; Peter Del Fante
Journal:  NMR Biomed       Date:  2011-05-11       Impact factor: 4.044

3.  Dietary intake of nutrients and its correlation with fatigue in multiple sclerosis patients.

Authors:  Sama Bitarafan; Mohammad-Hossein Harirchian; Shahriar Nafissi; Mohammad-Ali Sahraian; Mansoureh Togha; Fereydoun Siassi; Ahmad Saedisomeolia; Elham Alipour; Nakisa Mohammadpour; Maryam Chamary; Niyaz Mohammadzadeh Honarvar; Ali-Akbar Saboor-Yaraghi
Journal:  Iran J Neurol       Date:  2014
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.